Drug Depot, Inc., doing business as APS Pharmacy, is recalling approximately 9,440 vials of various injectable medications due to a lack of sterility assurance. The recall includes products such as Gonadorelin and several formulations of Testosterone (Testosterone Cypionate combined with Anastrozole, DHEA, or Propionate) packaged in multi-dose 10ml vials. Using non-sterile injectable products can lead to serious health complications, though no injuries or incidents have been reported to date. These medications were sold nationwide and in Puerto Rico.
Medications that are intended to be sterile but lack sterility assurance pose a significant risk of causing serious infections when injected. These infections can be life-threatening or result in permanent medical issues.
You have 2 options:
Recall #: D-0728-2022
Recall #: D-0729-2022
Recall #: D-0730-2022
Recall #: D-0731-2022
Recall #: D-0732-2022
Recall #: D-0733-2022
Recall #: D-0734-2022
Recall #: D-0735-2022
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.